Your new experience awaits. Try the new design now and help us make it even better

RETRACTION article

Front. Mol. Biosci., 18 November 2025

Sec. Cellular Biochemistry

Volume 12 - 2025 | https://doi.org/10.3389/fmolb.2025.1727243

Retraction: Circular ribonucleic acid circFTO promotes angiogenesis and impairs blood–retinal barrier via targeting the miR-128-3p/Thioredoxin interacting protein axis in diabetic retinopathy

This article is a retraction of:

  1. RETRACTED: Circular Ribonucleic Acid circFTO Promotes Angiogenesis and Impairs Blood–Retinal Barrier Via Targeting the miR-128-3p/Thioredoxin Interacting Protein Axis in Diabetic Retinopathy

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Circular ribonucleic acid circFTO promotes angiogenesis and impairs blood–retinal barrier via targeting the miR-128-3p/Thioredoxin interacting protein axis in diabetic retinopathy

by Guo J, Xiao F, Ren W, Zhu Y, Du Q, Li Q and Li X (2021). Front. Mol. Biosci. 8:685466. doi: 10.3389/fmolb.2021.685466

The journal retracts the 4 August 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the data in the published Figure 6D, and the subsequent duplication 5 months later of this image in another journal’s published article (Bioengineered, 2021 December; 12 (2):10187–10198. doi: 10.1080/21655979.2021.2001217). The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

This retraction was approved by the Field Chief Editor of Frontiers in Molecular Bioscience and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.

Frontiers would like to thank Rene Aquarius for contacting the journal regarding the published article.

Citation: Frontiers Editorial Office (2025) Retraction: Circular ribonucleic acid circFTO promotes angiogenesis and impairs blood–retinal barrier via targeting the miR-128-3p/Thioredoxin interacting protein axis in diabetic retinopathy. Front. Mol. Biosci. 12:1727243. doi: 10.3389/fmolb.2025.1727243

Received: 17 October 2025; Accepted: 27 October 2025;
Published: 18 November 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.